20/20 Biolabs, Inc. Share Price
NASDAQ: AIDX$0.00
-$0.22 (--%) 20/20 Biolabs, Inc. Stock Performance
20/20 Biolabs, Inc. Share Price Chart
$0.00$0.00
L
H
20/20 Biolabs, Inc. Quarterly Profit & Loss
All figures in USD
About 20/20 Biolabs, Inc.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
20/20 Biolabs, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.22 | $0.22 | +5.69% |
Oct 2026 | $0.42 | $0.21 | -49.16% |
Sep 2026 | $0.56 | $0.41 | -33.06% |
Aug 2026 | $0.47 | $0.62 | +44.52% |
Jul 2026 | $0.59 | $0.43 | -21.86% |
Jun 2026 | $0.93 | $0.55 | -36.53% |
May 2026 | $1.60 | $0.86 | -43.09% |
Apr 2026 | $1.86 | $1.52 | -11.11% |
Mar 2026 | $3.53 | $1.71 | -52.17% |
Feb 2026 | $20.52 | $3.58 | N/A |